Intra Cellular Therapies Inc (ITCI)

Intra Cellular Therapies Inc Azioni (ITCI) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	9.66% 144.87	132.10	126.17	110.79	95.31
Operating Expenses	0.23% 165.82	166.20	155.89	157.97	143.70
Benefits Costs and Expenses	159.75	-	-	-	-
Costs And Expenses	3.88% 159.75	166.20	155.89	157.97	143.70
Operating Income/Loss	38.55% -20.95	-34.10	-29.71	-47.18	-48.39
Income/Loss From Continuing Operations Before Tax	111.27% -14.89	132.10	-24.21	-42.65	-44.04
Income Tax Expense/Benefit	19.87% 0.359	0.448	0.043	0.135	0.01
Income/Loss From Continuing Operations After Tax	46.65% -15.25	-28.58	-24.26	-42.78	-44.05
Net Income/Loss	46.65% -15.25	-28.58	-24.26	-42.78	-44.05
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	71,086% 96.88	0.1361	96.14	95.95	95.13
Diluted Average Shares	71,086% 96.88	0.1361	96.14	95.95	95.13
Basic Earnings Per Share	46.67% -0.16	-0.30	-0.25	-0.45	-0.46
Diluted Earnings Per Share	46.67% -0.16	-0.30	-0.25	-0.45	-0.46
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-